TY - JOUR
T1 - Na+-dependent transporters mediate HCO3- salvage across the luminal membrane of the main pancreatic duct
AU - Lee, Min Goo
AU - Ahn, Wooin
AU - Choi, Joo Young
AU - Luo, Xiang
AU - Seo, Jeong Taeg
AU - Schultheis, Patrick J.
AU - Shull, Gary E.
AU - Kim, Kyung Hwan
AU - Muallem, Shmuel
PY - 2000/6
Y1 - 2000/6
N2 - To study the roles of Na+-dependent H+ transporters, we characterized H+ efflux mechanisms in the pancreatic duct in wild-type, NHE2(-/-), and NHE3(-/-) mice. The pancreatic duct expresses NHE1 in the basolateral membrane, and NHE2 and NHE3 in the luminal membrane, but does not contain NHE4 or NHE5. Basolateral Na+-dependent H+ efflux in the microperfused duct was inhibited by 1.5 μM of the amiloride analogue HOE 694, consistent with expression of NHE1, whereas the luminal activity required 50 μM HOE 694 for effective inhibition, suggesting that the efflux might be mediated by NHE2. However, disruption of NHE2 had no effect on luminal transport, while disruption of the NHE3 gene reduced luminal Na+-dependent H+ efflux by ~45%. Notably, the remaining luminal Na+dependent H+ efflux in ducts from NHE3(-/-) mice was inhibited by 50 μM HOE 694. Hence, ~55% of luminal H+ efflux (or HCO3- influx) in the pancreatic duct is mediated by a novel, HOE 694-sensitive, Na+-dependent mechanism. H+ transport by NHE3 and the novel transporter is inhibited by cAMP, albeit to different extents. We propose that multiple Na+-dependent mechanisms in the luminal membrane of the pancreatic duct absorb Na+ and HCO3- to produce a pancreatic juice that is poor in HCO3- and rich in Cl- during basal secretion. Inhibition of the transporters during stimulated secretion aids in producing the HCO3--rich pancreatic juice.
AB - To study the roles of Na+-dependent H+ transporters, we characterized H+ efflux mechanisms in the pancreatic duct in wild-type, NHE2(-/-), and NHE3(-/-) mice. The pancreatic duct expresses NHE1 in the basolateral membrane, and NHE2 and NHE3 in the luminal membrane, but does not contain NHE4 or NHE5. Basolateral Na+-dependent H+ efflux in the microperfused duct was inhibited by 1.5 μM of the amiloride analogue HOE 694, consistent with expression of NHE1, whereas the luminal activity required 50 μM HOE 694 for effective inhibition, suggesting that the efflux might be mediated by NHE2. However, disruption of NHE2 had no effect on luminal transport, while disruption of the NHE3 gene reduced luminal Na+-dependent H+ efflux by ~45%. Notably, the remaining luminal Na+dependent H+ efflux in ducts from NHE3(-/-) mice was inhibited by 50 μM HOE 694. Hence, ~55% of luminal H+ efflux (or HCO3- influx) in the pancreatic duct is mediated by a novel, HOE 694-sensitive, Na+-dependent mechanism. H+ transport by NHE3 and the novel transporter is inhibited by cAMP, albeit to different extents. We propose that multiple Na+-dependent mechanisms in the luminal membrane of the pancreatic duct absorb Na+ and HCO3- to produce a pancreatic juice that is poor in HCO3- and rich in Cl- during basal secretion. Inhibition of the transporters during stimulated secretion aids in producing the HCO3--rich pancreatic juice.
UR - http://www.scopus.com/inward/record.url?scp=0001003651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0001003651&partnerID=8YFLogxK
U2 - 10.1172/JCI9207
DO - 10.1172/JCI9207
M3 - Article
C2 - 10841524
AN - SCOPUS:0001003651
SN - 0021-9738
VL - 105
SP - 1651
EP - 1658
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
ER -